Nordea underwrites Pronova loan
Norwegian pharmaceutical firm Pronova BioPharm is syndicating a Nkr2.38bn (Eu296m, $407m) five year loan that Nordea has underwritten.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
